These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 878042)

  • 1. [Cyclo-Progynon. A sequential preparation for treatment in the climacteric].
    Nathan E
    Ugeskr Laeger; 1977 Jun; 139(24):1438-40. PubMed ID: 878042
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum lipoprotein changes in climacteric women induced by sequential therapy with natural estrogens and medroxy-progesterone acetate or norgestrel.
    Vejtorp M; Christensen MS; Vejtorp L; Larsen JF
    Acta Obstet Gynecol Scand; 1986; 65(5):391-5. PubMed ID: 3535357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum lipids during treatment with norgestrel, oestradiol-valerate and cycloprogynon.
    Nielsen FH; Honoré E; Kristoffersen K; Secher NJ; Pedersen GT
    Acta Obstet Gynecol Scand; 1977; 56(4):367-70. PubMed ID: 602705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estrogen-gestagen prevention and treatment of uterine hemorrhages in the premenopause].
    Rachev E; Katsarova M; Trepechov S
    Akush Ginekol (Sofiia); 1989; 28(3):78-81. PubMed ID: 2802089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone treatment in menopause].
    Schindler AE
    MMW Munch Med Wochenschr; 1980 Jun; 122(26):967-9. PubMed ID: 6775194
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of the climacteric symptom complex with a new combined hormone preparation].
    Jurczok F
    Fortschr Med; 1976 Mar; 94(9):524-7. PubMed ID: 134967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclic estradiol valerate/levonorgestrel on periclimacteric syndrome and endometrial cytology.
    Castiglione A; Bierschwale M; Novoa O
    Clin Ther; 1985; 7(5):555-8. PubMed ID: 3931915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined estrogen and progestogen for the menopause.
    Mugglestone CJ; Swinhoe JR; Craft IL
    Acta Obstet Gynecol Scand; 1980; 59(4):327-9. PubMed ID: 7004052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of the climacteric syndrome with a combination of estrone sulfate and estradiol. Preliminary report].
    Ruiz Moreno JA; Rubio Lotvin B; De Larios NM; Bolio Arista R
    Ginecol Obstet Mex; 1973 Sep; 34(203):273-9. PubMed ID: 4756182
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of an estrogen-progestagen combination in reduced doses with contraceptive purpose].
    Foix A; Napoli J; Comparatore D; Garay M
    Obstet Ginecol Lat Am; 1978; 36(1-2):23-31. PubMed ID: 710732
    [No Abstract]   [Full Text] [Related]  

  • 11. [Estradiol valerianate in the treatment of female climacteric].
    Pĕrez de Salazar JL; Garcĭa Torres FZ; Ruiz Velasco V; Conde Manjarrez BI
    Ginecol Obstet Mex; 1971 Nov; 30(181):527-37. PubMed ID: 5131135
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment and prevention of premenopausal uterine hemorrhages with Trisequens].
    Rachev E; Katsarova M; Bŭrdarova I
    Akush Ginekol (Sofiia); 1991; 30(2):73-6. PubMed ID: 1883055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms.
    Cieraad D; Conradt C; Jesinger D; Bakowski M
    Arch Gynecol Obstet; 2006 May; 274(2):74-80. PubMed ID: 16491367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of climacteric symptoms by Folivirin and its effect on sexual activity (author's transl)].
    Kohoutek F; Finková A
    Cesk Gynekol; 1974 Sep; 39(8):608-10. PubMed ID: 4434526
    [No Abstract]   [Full Text] [Related]  

  • 15. A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
    Meuwissen JH; Beijers-De Bie L; Vihtamaki T; Tuimala R; Siseles N; Magaril C; The HS; Houben PW; Murga M; Spielmann D; De Villiers TJ
    Gynecol Endocrinol; 2001 Oct; 15(5):349-58. PubMed ID: 11727357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination of hormone replacement therapy with buspirone in the treatment of climacteric complaints].
    Szántó F
    Orv Hetil; 2000 Apr; 141(16):835-7. PubMed ID: 10817010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: The treatment of climacteric disorders with a combination of estradiol and testosterone--an outline of the pathogenesis of psychic symptoms in the climacterium.
    Navrátil J; Nováková D; Pichner J
    Act Nerv Super (Praha); 1975; 17(4):307-8. PubMed ID: 1221812
    [No Abstract]   [Full Text] [Related]  

  • 19. Choice of oestrogen/progestagen regimen, for symptoms of the climacteric.
    Smith AM
    Lancet; 1979 Sep; 2(8143):630. PubMed ID: 90284
    [No Abstract]   [Full Text] [Related]  

  • 20. [Extended clinical studies on a new biphasic preparation].
    Lachnit U
    Ther Ggw; 1974 Sep; 113(9):1486-505. PubMed ID: 4612855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.